MedPath

Efficacy of Magnesium and Alpha Lipoic Acid Supplementation in Reducing Premature Uterine Contractions

Phase 4
Completed
Conditions
Pregnancy
Interventions
Dietary Supplement: Magnesium plus alpha-lipoic acid
Drug: Placebo
Registration Number
NCT02016495
Lead Sponsor
AGUNCO Obstetrics and Gynecology Centre
Brief Summary

To evaluate whether a combined supplementation of magnesium and lipoic acid is able to significantly reduce the incidence of uterine contractions and related episodes of hospitalization in pregnant women.

Detailed Description

Primary prevention of preterm labor is based on the early identification of risk factors and on appropriate treatments. Although several drugs are currently used, the identification of effective and safe agents able to improve both maternal and fetal health is still warranted.

In this study the efficacy a formulation based on magnesium and alpha-lipoic acid has been compared with placebo to evaluate the incidence of reduction of preterm delivery.

Three hundred pregnant women at 14-34 weeks of gestation were enrolled and randomly divided to receive a daily single tablet containing magnesium and alpha-lipoic acid supplement or placebo until delivery.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • 14-34 weeks of gestation
Exclusion Criteria
  • Preexisting diabetes mellitus
  • Systolic blood pressure >140mm Hg
  • Cancer
  • lupus
  • hepatitis
  • HIV/AIDS
  • Diagnosed alcohol or chemical dependency

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Magnesium + Lipoic AcidMagnesium plus alpha-lipoic acid-
PlaceboPlacebo-
Primary Outcome Measures
NameTimeMethod
Number of women with frequent and persistent episodes of preterm uterine contractions associated with painFrom baseline (beginning of the treatment) until delivery
Number of women with sporadic episodes of preterm uterine contractionFrom baseline (beginning of the treatment) until delivery
Number of women needed for hospital admission for threatened preterm labourFrom baseline (beginning of the treatment) until delivery
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinica Villa delle Querce

🇮🇹

Naples, Italy

© Copyright 2025. All Rights Reserved by MedPath